AlbemarleALB -1.56%75 ROE % is 13.17% as of Mar. 2026, which is 13% above its 10-year median of 11.68. GuruFocus rates ALB with a GF Score™ of 75/100 and a GF Value™ of $83.50 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,590 Chemicals companies, Albemarle ranks worse than 78.11% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Albemarle's annualized net income for the quarter that ended in Mar. 2026 was $1,276 Mil. Albemarle's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $9,692 Mil. Therefore, Albemarle's annualized ROE % for the quarter that ended in Mar. 2026 was 13.17%.
The historical rank and industry rank for Albemarle's ROE % or its related term are showing as below:
ALB'
s ROE % Range Over the Past 10 Years
Min: -12.18 Med: 11.68 Max: 39.53
Current: -2.35
During the past 13 years, Albemarle's highest ROE % was 39.53%. The lowest was -12.18%. And the median was 11.68%.
ALB's ROE % is ranked worse than 78.11% of 1590
companies
in the Chemicals industry
Industry Median: 5.195
vs ALB: -2.35
Albemarle (NYSE:ALB) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Albemarle ROE % Related Terms
Albemarle ROE % Historical Data
* Premium members only.
The historical data trend for Albemarle's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Albemarle's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Albemarle ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Albemarle's ROE % distribution charts can be found below:
* The bar in red indicates where Albemarle's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Albemarle (ALB) has a ROE % of 13.17% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Albemarle and its competitors. This is 13% above median its historical median of 11.68. According to the industry distribution chart, Albemarle ranks #1242 out of 1590 companies in the Chemicals industry, placing it in the top 78.1%.
Is Albemarle's ROE % too high?
Albemarle's current ROE % of 13.17% is 13% above median its 10-year median of 11.68. The Chemicals industry median ROE % is 5.20. Albemarle's value of 13.17% is 153.5% above this industry median. Based on the distribution chart, Albemarle ranks #1242 out of 1590 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Albemarle has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Albemarle's ROE % compare to LYB and DD?
According to the Chemicals industry distribution chart, Albemarle ranks #1242 out of 1590 companies for ROE %. This places Albemarle in the lower half of its industry. The industry median ROE % is 5.20. Albemarle's value of 13.17% is 153.5% above this benchmark. While the company's 10-year median is 11.68 vs. the industry median of 5.20, Albemarle has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.20, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Albemarle's current ROE % of 13.17% is 153.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Albemarle and its competitors. For the Chemicals industry, the median ROE % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albemarle's current ROE % is 13.17%, which is 13% above median its own 10-year median of 11.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albemarle stock overvalued right now?
Based on GuruFocus' analysis, Albemarle (ALB) is currently considered Significantly Overvalued. The stock's GF Value™ is $83.50, compared to a current price of $147.64 — trading 76.8% above its estimated fair value. The current ROE % is 13.17%, which is 13% above median its 10-year median of 11.68 and 153.5% above the Chemicals industry median of 5.20. Albemarle's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Albemarle (ALB), the current ROE % is 13.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Albemarle (ALB) Overvalued in 2026?
Based on GuruFocus' analysis, Albemarle stock appears to be overvalued.
The current stock price of $147.64 is trading 76.8% above its estimated GF Value™ of $83.50.
GuruFocus considers Albemarle to be Significantly Overvalued.
Key valuation signals for ALB:
ROE %: 13.17% (13% above median its 10-year median of 11.68)
GF Value™: $83.50 vs. price of $147.64 (76.8% above fair value)
Industry Position: 153.5% above the Chemicals median (#1242 of 1590)
No single metric tells the full story. See the ALB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
75GF Score
Get the complete analysis for ALB
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALB has been successfully added to your 
